Referencias Seleccionadas:
- Amgen, Inc. 2023. Otezla product label. https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/otezla/otezla_pi_english.ashx. [Accessed February 2024].
- Bangsgaard N, et al. 2015 Treating Psoriasis During Pregnancy: safety and efficacy of treatments. Am J Clin Dermatol. 16(5):389-98.
- Celgene Corporation. 2015. Otezla product label. Accessed April 2020 https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/otezla/otezla_pi_english.ashx
- Hoffman MB, et al. 2015. Psoriasis during pregnancy: characteristics and important management recommendations. Expert Rev Clin Immunol. 11(6):709-20
- Kaushik SB, et al. 2019. Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections. J Am Acad Dermatol. 80(1):43-53.
- Rademaker M,et al. 2018. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration. Australas J Dermatol. 59(2):86-100
- Saavedra MA, et al. 2018. Targeted drugs in spondyloarthritis during pregnancy and lactation. Pharmacol Res. 136:21-28.
